Vimarsana
Biggest News Aggregation in the World

Study Clinical Global Impression News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Clinical Global Impression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Clinical Global Impression Today - Breaking & Trending Today

BioVie to announce topline data from Phase 3 Alzheimer's Disease trial by year-end - Vimarsana News

BioVie to announce topline data from Phase 3 Alzheimer's Disease trial by year-end

BioVie Inc (NASDAQ:BIVI) said the last patient has completed their final visit at week 30 in their Phase 3 study of investigational therapy NE3107 in...

Methylphenidate Safe and Effective in Reducing Apathy in Alzheimer Disease - Vimarsana News

Methylphenidate Safe and Effective in Reducing Apathy in Alzheimer Disease

Methylphenidate at 10 mg twice daily for reducing apathy in patients with Alzheimer disease has a sustainable effect for at least 6 months.